Article: FDA Approves SINGULAIR For Seasonal Allergic Rhinitis; A New Class of Therapy for the Treatment of Seasonal Allergic Rhinitis -Also Known as Hay Fever-.

Business Editors/Health & Pharmaceutical Writers

NOTE TO MEDIA: Multimedia assets available

A photo is available at URL:

http://www.businesswire.com/cgi-bin/photo.cgi?pw.010203/bb3

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Jan. 2, 2003

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!